**Question:** Losaan is similar to enalapril in all of the following features except:

A. Losaan is a newer angiotensin-converting enzyme (ACE) inhibitor, while enalapril is an older one.
B. Losaan is mainly used for the treatment of hypertension, while enalapril is used for both hypertension and heart failure.
C. Losaan has a faster onset of action compared to enalapril.
D. Losaan is available in a single dosage form, while enalapril is available in multiple dosage forms.

**Correct Answer:** C. Losaan has a faster onset of action compared to enalapril.

**Core Concept:**
Angiotensin-converting enzyme (ACE) inhibitors are a class of medications used to treat hypertension and heart failure. ACE inhibitors work by blocking the formation of angiotensin II, a potent vasoconstrictor and aldosterone stimulator. This leads to vasodilation and reduction in aldosterone secretion, resulting in reduced blood pressure and fluid retention.

**Why the Correct Answer is Right:**
Losaan has a faster onset of action compared to enalapril due to its unique pharmacokinetic properties. Losaan is formulated as a prodrug, which means it is not active until it reaches the intestine. Once in the intestine, Losaan is converted to its active form, enalaprilat, which has a faster onset of action than enalapril. This is because enalapril acts as a direct inhibitor of ACE, while Losaan needs to be converted to its active form for the same effect, and this conversion process adds an extra step to the pharmacokinetics.

**Why Each Wrong Option is Incorrect:**
A. Both Losaan and enalapril are ACE inhibitors, but the difference lies in their development timeline. Losaan is a newer drug, while enalapril has been in use for a longer time, making this statement incorrect.
B. Losaan and enalapril are equally effective in treating hypertension and heart failure. The difference lies in their onset of action, but not their overall therapeutic efficacy.
D. Losaan and enalapril may have differences in their formulation, but the dosage forms of both drugs are not the primary reason for the difference in onset of action.

**Clinical Pearls:**
1. Losaan's unique pharmacokinetic properties allow for a faster onset of action compared to enalapril, which directly inhibits ACE.
2. As both drugs are effective in treating hypertension and heart failure, focusing solely on the onset of action may lead to confusion in distinguishing between them.
3. The choice of medication depends on the patient's specific needs, comorbidities, and physician preference, rather than the difference in onset of action.